Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis

Yonsei Medical Journal

Volumn 53, Issue 1, 2012, Pages 164-171

  Lim, Seung Kwan ^a   Park, In Whee ^a   Lee, Wee Gyo ^a   Kim, Hyun Kyung ^a   Choi, Young Hwa ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Acute pyelonephritis; Antimicrobial resistance; Ciprofloxacin resistance; Escherichia coli

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN;

ACUTE PYELONEPHRITIS; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; COMMUNITY ONSET ACUTE PYELONEPHRITIS; ESCHERICHIA COLI; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; URINE CULTURE;

ACUTE DISEASE; ADULT; AGED; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYELONEPHRITIS;

EID: 84255184762     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2012.53.1.164     Document Type: Article

References (29)

1. Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol 2003;13:144-50.
2. Tenner SM, Yadven MW, Kimmel PL. Acute pyelonephritis. Preventing complications through prompt diagnosis and proper therapy. Postgrad Med 1992;91:261-8.
3. Ramakrishnan K, Scheid DC. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician 2005;71:933-42.
4. Stamm WE. Urinary tract infection, pyelonephritis, and prostatitis. In: Harrison TR, Braunwald E, editors. Harrison's principles of internal medicine. 17 ed. New York: McGraw-Hill; 2008. p.1820-7.
5. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001;135:41-50.
6. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-34.
7. Wie SH, Chang UI, Kim HW, Kim YS, Kim SY, Hur J, et al. Clinical features and antimicrobial resistance among clinical isolates of women with community-acquired acute pyelonephritis in 2001-2006. Infect Chemother 2007;39:9-16.
8. Kim KY, Kim CS, Lim DH. The ciprofloxacin resistance pattern of escherichia coli isolated from female patients with community- acquired urinary tract infection in the Jeonnam and Gwangju region for the recent 2-years. Korean J Urol 2008;49:540-8.
9. Hwang BY, Lee JG, Park DW, Lee YJ, Kim SB, Eom JS, et al. Antimicrobial susceptibility of causative microorganisms in adults with acute pyelonephritis at one university-affiliated hospital in southwestern Seoul. Infect Chemother 2003;35:277-82.
10. Kim JH, Lee CS, Choi NW, Park SK, Lee CH, Kim G, et al. Quinolone resistance in community-acquired acute pyelonephritis. Korean J Nephrol 2006;25:571-8.
11. Kim YR, Huh JS, Kang SH. Patterns of antimicrobial susceptibility of the causative bacteria of urinary tract infections in recent years in an island region. Korean J Clin Microbiol 2007;10:19-24.
12. Jeong KY, Park JO, Kim DK, Kwak YH. Treatment of acute pyelonephritis in emergency department; comparison of the efficacy of ciprofloxacin and 3rd generation cephalosporin. Infect Chemother 2007;39:296-303.
13. Kim YJ, Lee SH, Kang YN, Kim WC, Kim SI, Wie SH, et al. The trend of antibiotic production in Korea during 1981-2003. Infect Chemother 2005;37:271-9.
14. Goettsch W, van Pelt W, Nagelkerke N, Hendrix MG, Buiting AG, Petit PL, et al. Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000;46:223-8.
15. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
16. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32.
17. Nicolle LE. A practical guide to the management of complicated urinary tract infection. Drugs 1997;53:583-92.
18. McGregor JC, Allen GP, Bearden DT. Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis. Ther Clin Risk Manag 2008;4:843-53.
19. Ronald AR, Harding GK. Complicated urinary tract infections. Infect Dis Clin North Am 1997;11:583-92.
20. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 18th international supplement M100-S18. Document M7-A7, Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
21. Robin F, Delmas J, Schweitzer C, Bonnet R. Evaluation of the Vitek-2 extended-spectrum beta-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases. Clin Microbiol Infect 2008;14:148-54.
22. Kahlmeter G; ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003;51:69-76.
23. Rodriguez-Baño J, Paterson DL. A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. Clin Infect Dis 2006;42:935-7.
24. Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ; EMERGEncy ID NET Study Group. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008;47:1150-8.
25. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281:736-8.
26. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745-58.
27. Lee JM, Hwang KW, Jegal S. Antimicrobial resistance in Escherichia coli isolated from healthy volunteers of the community. Korean J Clin Microbiol 2007;10:32-6.
28. Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 2007;45:273-80.
29. Lee JS, Rho SH, Kim SE, Nam TM, Kim JS, Kim SG, et al. A study on the clinical and microbiologic features of community-acquired acute pyelonephritis for the recent 5 years in a university hospital. Korean J Nephrol 2002;21:905-13.